This cutting-edge technology could 3D bioprint whole organs in the future, potentially saving the lives of many.

These stem cells could be used to develop cell-based therapies for blindness, diabetes and genetic disorders.

Pluristem’s stem-cell technology may hold cure for victims affected by the 2011 Fukushima nuclear disaster.

Israeli company Pluristem has developed a platform that delivers therapeutic proteins derived from the human placenta, which could potentially cure many diseases.